Closed
SectorHealthcare
440.95 -0.5
24h
Min
439.4
Max
446.24
Income | -267M 646M |
---|---|
Sales | -142M 2.8B |
P/E Sector Avg | 30.42 50.291 |
EPS | 4.06 |
Profit margin | 23.33 |
Employees | 6,100 |
EBITDA | -404M 782M |
Recommendations | Buy |
---|---|
12 Months Forecast | +15.88% upside |
Next Earnings | 31 lip 2025 |
---|
Market Cap | -5.9B 114B |
---|---|
Previous open | 441.45 |
Previous close | 440.95 |
By Acuity
33%
67%
86 / 380 Ranking in Healthcare
By Trading Central
Confidence
Very Strong Bearish Evidence
Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.
Price change
By TipRanks
12 Months Forecast
Average 513.8 USD 15.88%
High 621 USD
Low 420 USD
Based on 26 Wall Street analysts offering 12 month price targets forVertex Pharmaceuticals Inc - Dist in the last 3 months.
By Acuity
News Sentiment
Bullish Evidence
Volatility
Below average
News Volume (RCV)
Above average
Selling and administration expenses
Operating expenses
Pre-tax profit
Sales
Cost of sales
Gross profit on sales
Interest expense on debt
EBITDA
Operating profit
$